NYSE:HIMSHealthcare
Why Hims & Hers Health (HIMS) Is Up 32.3% After Novo Nordisk GLP-1 Deal And Telehealth Push
In recent weeks, Hims & Hers Health has secured a partnership with Novo Nordisk to offer GLP-1 weight-loss drugs, completed the acquisition of digital health platform Eucalyptus, and appointed Dr. Anant Vinjamoori as Chief Medical Officer, while investors await an FDA Pharmacy Compounding Advisory Committee decision on adding several peptides to the 503A bulk substances list.
Together, these moves deepen the company’s role in chronic weight management and broaden its telehealth footprint,...